Reata Pharmaceuticals Inc

JPMORGAN CHASE & CO

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/11/2023

Shares

206,223

Value ($000)

21,026

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/11/2023	21,026	0.0%	206,223	6/30/2023
2023 Q1	5/18/2023	11,204	0.0%	123,243	3/31/2023
2022 Q4	2/13/2023	6,361	0.0%	167,416	12/31/2022
2022 Q3	11/14/2022	3,345	0.0%	133,060	9/30/2022
2022 Q2	8/11/2022	1,347	0.0%	44,310	6/30/2022
2022 Q1	5/11/2022	923	0.0%	28,162	3/31/2022
2021 Q4	2/11/2022	627	0.0%	23,764	12/31/2021
2021 Q3	11/12/2021	2,620	0.0%	26,037	9/30/2021
2021 Q2	8/12/2021	3,510	0.0%	24,795	6/30/2021
2021 Q1	5/12/2021	3,697	0.0%	37,080	3/31/2021
2020 Q4	2/19/2021	5,060	0.0%	40,934	12/31/2020
2020 Q3	11/12/2020	3,468	0.0%	36,594	9/30/2020
2020 Q2	8/11/2020	6,512	0.0%	41,735	6/30/2020
2020 Q1	5/12/2020	6,084	0.0%	42,148	3/31/2020
2019 Q4	2/11/2020	11,314	0.0%	55,340	12/31/2019